KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Keysight Technologies (KEYS) Research & Development (2016 - 2026)

Keysight Technologies' Research & Development history spans 13 years, with the latest figure at $303.0 million for Q1 2026.

  • For Q1 2026, Research & Development rose 21.69% year-over-year to $303.0 million; the TTM value through Jan 2026 reached $1.1 billion, up 13.35%, while the annual FY2025 figure was $1.0 billion, 9.58% up from the prior year.
  • Research & Development reached $303.0 million in Q1 2026 per KEYS's latest filing, up from $258.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $303.0 million in Q1 2026 to a low of $206.0 million in Q3 2022.
  • Average Research & Development over 5 years is $232.5 million, with a median of $227.0 million recorded in 2023.
  • Peak YoY movement for Research & Development: decreased 0.48% in 2022, then grew 21.69% in 2026.
  • A 5-year view of Research & Development shows it stood at $215.0 million in 2022, then grew by 1.4% to $218.0 million in 2023, then rose by 6.88% to $233.0 million in 2024, then increased by 10.73% to $258.0 million in 2025, then rose by 17.44% to $303.0 million in 2026.
  • Per Business Quant, the three most recent readings for KEYS's Research & Development are $303.0 million (Q1 2026), $258.0 million (Q4 2025), and $250.0 million (Q3 2025).